By Paul Arco
The global Hair Loss & Growth Treatment market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Hair Loss & Growth Treatment market. The report focuses on well-known providers in the global Hair Loss & Growth Treatment industry, market segments, competition, and the macro environment.
Under COVID-19 Outbreak, how the Hair Loss & Growth Treatment Industry will develop is also analyzed in detail in Chapter 1.7 of the report., In Chapter 2.4, we analyzed industry trends in the context of COVID-19., In Chapter 3.5, we analyzed the impact of COVID-19 on the product industry chain based on the upstream and downstream markets., In Chapters 6 to 10 of the report, we analyze the impact of COVID-19 on various regions and major countries., In chapter 13.5, the impact of COVID-19 on the future development of the industry is pointed out. A holistic study of the market is made by considering a variety of factors, from demographics conditions and business cycles in a particular country to market-specific microeconomic impacts. The study found the shift in market paradigms in terms of regional competitive advantage and the competitive landscape of major players. Download PDF Sample of Hair Loss and Growth Treatment Market report @ https://www.arcognizance.com/enquiry-sample/1227868 Key players in the global Hair Loss & Growth Treatment market covered in Chapter 4:, Pharma Medico, Unilever, L’Oreal, Henkel, Procter & Gamble, Taisho, Bayer In Chapter 11 and 13.3, on the basis of types, the Hair Loss & Growth Treatment market from 2015 to 2026 is primarily split into:, Shampoos and Conditioners, Medicine Product In Chapter 12 and 13.4, on the basis of applications, the Hair Loss & Growth Treatment market from 2015 to 2026 covers:, Men, Women Brief about Hair Loss and Growth Treatment Market Report with TOC@https://www.arcognizance.com/report/global-hair-loss-and-growth-treatment-market-report-2020-by-key-players-types-applications-countries-market-size-forecast-to-2026-based-on-2020-covid-19-worldwide-spread Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2026) of the following regions are covered in Chapter 5, 6, 7, 8, 9, 10, 13:, North America (Covered in Chapter 6 and 13), United States, Canada, Mexico, Europe (Covered in Chapter 7 and 13), Germany, UK, France, Italy, Spain, Russia, Others, Asia-Pacific (Covered in Chapter 8 and 13), China, Japan, South Korea, Australia, India, Southeast Asia, Others, Middle East and Africa (Covered in Chapter 9 and 13), Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Others, South America (Covered in Chapter 10 and 13), Brazil, Argentina, Columbia, Chile, Others
In the early stages of COVID-19, as state restrictions took hold, a segment of health care saw a significant decrease in patient volume, including cosmetic and reconstructive surgery. But as the pandemic continues, patients are now using this time to have a necessary surgery or schedule an elective procedure that they may have been putting off.
“Our patient volume was obviously down,” said Dr. Pedro Rodriguez, Plastic Surgeon, OSF HealthCare. “However, what we do in terms of our office is not only cosmetic plastic surgery but also reconstructive plastic surgery. Seventy percent of what we do is necessary. We treat a lot of patients that have very significant needs therefore the overall effect was initially decreased volumes and now it’s an overwhelming volume of patients.”
The most commonly seen cases include skin cancers, breast cancer and breast reconstruction surgery. Abnormal structures of the body due to disease, infection or trauma are also treated by surgery.
“We try to educate our patients, we try to educate the public and most of all we try to educate other physicians,” said Dr. Pedro Rodriguez, Plastic Surgeon, OSF HealthCare. “Because COVID is here does not mean cancer stops. COVID does not mean patients fail to get sick. We have to be proactive, cautious, and follow the guidelines and protect all of our patients. However, we still need to provide care, that’s what we’re here to do.”
As for elective surgeries, such as microdermabrasion, many patients are taking advantage of prolonged time at home or those who are now working from home and they are finally making an appointment. Dr. Rodriguez says many patients feel more comfortable scheduling a procedure knowing they have plenty of time to recover in the comforts of their home.
“We’ve seen a significant increase in elective surgeries, cosmetic wise,” said Dr. Pedro Rodriguez, Plastic Surgeon, OSF HealthCare. “Patients are finally working from home. They actually have the time to recover; they have the finances to recover. So we have seen an increase in cosmetic procedures because of those facts.”
Hospitals have seen an uptick in telemedicine visits during the pandemic. But Dr. Rodriguez says the best option remains in person visits to your physician’s office, especially when surgery is involved. Patient exams are vital and a face-to-face conversation is a good way for your physician to explain what surgery will entail and to answer any questions. Hospital staff continues to mask up, wash their hands and keep all exam rooms clean.
Whether it’s reconstructive surgery or an elective procedure, Dr. Rodriguez stresses speaking with your physician immediately with any questions or concerns.
“Please, if you have a medical condition and need care, come and see us. If you have breast cancer, please come see us. If you have any concerns, please come see us,” said Dr. Pedro Rodriguez, Plastic Surgeon, OSF HealthCare. “We are providing safe care, we are providing excellent care, and we are going above and beyond. Even though we are operating in a very difficult situation with our current COVID guidelines, we’re still providing safe and appropriate care for all of our patients.”
